SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn:
“Recent advances in nuclear medicine are reshaping the diagnostic and therapeutic landscape of oncology. Join us for a session dedicated to exploring the latest progress in the field, the impact of workforce limitations, and the evolving role of patients in guiding care pathways.
Key topics:
- Progress in nuclear medicine
- Challenges in heterogeneous HTA evaluations
- The patient perspective
- Moving forward in neuroendocrine cancers: evidence from Belgium
CME accredited and free of charge
This session is part of the SPCC Sustaining Corporate Programme 2026.
Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.”
Other articles about SPCC on OncoDaily